Viemed Healthcare, Inc.
Simbolis: VMD
NASDAQ
9.38
USDRinkos kaina šiandien
26.7260
P/E santykis
0.0462
PEG koeficientas
361.03M
MRK kapitalizacija
- 0.00%
DIV pajamingumas
Viemed Healthcare, Inc. (VMD) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 12.8 | 16.9 | 28.4 | ||||||||
balance-sheet.row.short-term-investments | 0 | 0 | -2 | 0 | ||||||||
balance-sheet.row.net-receivables | 0 | 18.4 | 15.4 | 14.7 | ||||||||
balance-sheet.row.inventory | 0 | 4.6 | 3.6 | 2.5 | ||||||||
balance-sheet.row.other-current-assets | 0 | 2.4 | 3.8 | 1.7 | ||||||||
balance-sheet.row.total-current-assets | 0 | 38.2 | 39.7 | 47.3 | ||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 76.5 | 68.4 | 62.8 | ||||||||
balance-sheet.row.goodwill | 0 | 29.6 | 0 | 0 | ||||||||
balance-sheet.row.intangible-assets | 0 | 0.6 | 0 | 0 | ||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 30.3 | 0 | 0 | ||||||||
balance-sheet.row.long-term-investments | 0 | 3.9 | 4.2 | 2.2 | ||||||||
balance-sheet.row.tax-assets | 0 | 4.5 | 3.1 | 4.8 | ||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.7 | 1.6 | 0.9 | ||||||||
balance-sheet.row.total-non-current-assets | 0 | 115.9 | 77.3 | 70.7 | ||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-assets | 0 | 154.1 | 117 | 118 | ||||||||
balance-sheet.row.account-payables | 0 | 4.2 | 2.6 | 3.2 | ||||||||
balance-sheet.row.short-term-debt | 0 | 2 | 0.5 | 1.9 | ||||||||
balance-sheet.row.tax-payables | 0 | 2.1 | 0 | 0 | ||||||||
balance-sheet.row.long-term-debt-total | 0 | 6 | 0.2 | 4.6 | ||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||
balance-sheet.row.other-current-liab | 0 | 19.6 | 11.1 | 8.9 | ||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 8.8 | 1.1 | 5.3 | ||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.capital-lease-obligations | 0 | 2.3 | 0.7 | 0.7 | ||||||||
balance-sheet.row.total-liab | 0 | 40.8 | 19.9 | 23.1 | ||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0.3 | 0 | ||||||||
balance-sheet.row.common-stock | 0 | 18.6 | 15.1 | 14 | ||||||||
balance-sheet.row.retained-earnings | 0 | 79.1 | 69.8 | 73.3 | ||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | -0.3 | -0.3 | ||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 15.6 | 12.1 | 7.7 | ||||||||
balance-sheet.row.total-stockholders-equity | 0 | 113.3 | 97.1 | 94.8 | ||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 154.1 | 117 | 118 | ||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-equity | 0 | 113.3 | 97.1 | 94.8 | ||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||
Total Investments | 0 | 3.9 | 2.2 | 2.2 | ||||||||
balance-sheet.row.total-debt | 0 | 10.3 | 0.7 | 6.5 | ||||||||
balance-sheet.row.net-debt | 0 | -2.5 | -16.2 | -21.9 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 10.4 | 6.2 | 9.1 | ||||||||
cash-flows.row.depreciation-and-amortization | 0 | 22.3 | 15.6 | 11.3 | ||||||||
cash-flows.row.deferred-income-tax | 0 | -1.5 | 1.7 | 3.9 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 5.8 | 5.2 | 5.2 | ||||||||
cash-flows.row.change-in-working-capital | 0 | 7.9 | -10.1 | -13.6 | ||||||||
cash-flows.row.account-receivables | 0 | -1.1 | -12.6 | -7.3 | ||||||||
cash-flows.row.inventory | 0 | -0.5 | 0.3 | -0.2 | ||||||||
cash-flows.row.account-payables | 0 | -0.9 | -0.3 | 0.1 | ||||||||
cash-flows.row.other-working-capital | 0 | 10.4 | 2.4 | -6.1 | ||||||||
cash-flows.row.other-non-cash-items | 0 | 1 | 9.1 | 6.6 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -26.6 | -22.9 | -19.7 | ||||||||
cash-flows.row.acquisitions-net | 0 | -26.5 | -0.1 | -0.6 | ||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -2 | -0.6 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | -2.6 | 0 | 0.6 | ||||||||
cash-flows.row.other-investing-activites | 0 | 2.6 | 1.1 | 0.6 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -53.1 | -24 | -19.7 | ||||||||
cash-flows.row.debt-repayment | 0 | -2.3 | -5.8 | -4 | ||||||||
cash-flows.row.common-stock-issued | 0 | 1.3 | 0.3 | 0.1 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | -0.6 | -9.7 | -1.4 | ||||||||
cash-flows.row.dividends-paid | 0 | -0.4 | -0.3 | -0.1 | ||||||||
cash-flows.row.other-financing-activites | 0 | 4.9 | 0.3 | 0.1 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 2.9 | -15.3 | -5.3 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.1 | 0 | 0 | ||||||||
cash-flows.row.net-change-in-cash | 0 | 6.9 | -11.5 | -2.6 | ||||||||
cash-flows.row.cash-at-end-of-period | 0 | 12.8 | 16.9 | 28.4 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 5.9 | 28.4 | 31 | ||||||||
cash-flows.row.operating-cash-flow | 0 | 46 | 27.7 | 22.5 | ||||||||
cash-flows.row.capital-expenditure | 0 | -26.6 | -22.9 | -19.7 | ||||||||
cash-flows.row.free-cash-flow | 0 | 19.5 | 4.8 | 2.8 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 186.4 | 138.8 | 117.1 | ||||||||
income-statement-row.row.cost-of-revenue | 0 | 72.9 | 54.2 | 43.7 | ||||||||
income-statement-row.row.gross-profit | 0 | 113.4 | 84.7 | 73.4 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 0 | 0.1 | 0 | -0.8 | ||||||||
income-statement-row.row.operating-expenses | 0 | 97.6 | 76.1 | 61.4 | ||||||||
income-statement-row.row.cost-and-expenses | 0 | 170.6 | 130.2 | 105 | ||||||||
income-statement-row.row.interest-income | 0 | 0 | 0.2 | 0.3 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.2 | 0.3 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -1.1 | 0.7 | 0.9 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 0 | 0.1 | 0 | -0.8 | ||||||||
income-statement-row.row.total-operating-expenses | 0 | -1.1 | 0.7 | 0.9 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.2 | 0.3 | ||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 22.3 | 16.3 | 12.2 | ||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||
income-statement-row.row.operating-income | 0 | 15.8 | 8.3 | 11.6 | ||||||||
income-statement-row.row.income-before-tax | 0 | 14.7 | 9 | 12.5 | ||||||||
income-statement-row.row.income-tax-expense | 0 | 4.2 | 2.8 | 3.4 | ||||||||
income-statement-row.row.net-income | 0 | 10.2 | 6.2 | 9.1 |
Dažnai užduodami klausimai
Kas yra Viemed Healthcare, Inc. (VMD) bendras turtas?
Viemed Healthcare, Inc. (VMD) bendras turtas yra 154102510.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.609.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 0.228.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.053.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.077.
Kas yra Viemed Healthcare, Inc. (VMD) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 10243000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 10271179.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 97637306.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 0.000.